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Abstract. Acoustic and therapeutic properties of Doxorubicin (DOX) and paclitaxel (PTX)- 
loaded perfluorocarbon nanoemulsions have been investigated in a mouse model of ovarian 
cancer. The nanoemulsions were stabilized by two biodegradable amphiphilic block copolymers 
that differed in the structure of the hydrophobic block. Acoustic droplet vaporization (ADV) and 
cavitation parameters were measured as a function of ultrasound frequency, pressure, duty 
cycles, and temperature. The optimal parameters that induced ADV and inertial cavitation of the 
formed microbubbles were used in vivo in the experiments on the ultrasound-mediated 
chemotherapy of ovarian cancer. A combination tumor treatment by intravenous injections of 
drug-loaded perfluoropentane nanoemulsions and tumor-directed 1-MHz ultrasound resulted in a 
dramatic decrease of ovarian or breast carcinoma tumor volume and sometimes complete tumor 
resolution. However, tumors often recurred three to six weeks after the treatment indicating that 
some cancer cells survived the treatment. The recurrent tumors proved more aggressive and 
resistant to the repeated therapy than initial tumors suggesting selection for the resistant cells 
during the first treatment.




During the last decade, a number o f  novel modalities for a targeted tumor therapy 
have been suggested. These modalities are based on developing stimuli-responsive 
nanoparticles that release their drug load in response to environmental or physical 
stimuli, such as pH, hyperthermia, light, or ultrasound. In our previous work, we have 
developed the nanoemulsions that converted into nano- and microbubbles in situ upon 
injection or under the action o f therapeutic ultrasound [1], [2], These systems 
combined passive tumor-targeting capacity with ultrasound responsiveness and could 
be used for combining ultrasonography with ultrasound-mediated chemotherapy. Here 
we describe acoustic properties o f  these systems.
The nanoparticles we have developed are composed o f  nano- or micro-scale 
echogenic emulsions that convert into nano- and/or microbubbles in situ upon 
injection and tumor sonication. A set o f  their properties includes drug carrying, tumor-
CPI 1 1 3 ,8th International Symposium on Therapeutic Ultrasound, edited by E. S. Ebbini 
©  2009 American Institute o f  Physics 978-0-7354-0650-6/09/S25.00
124
targeting, enhancing intracellular drug delivery, and enhancing the ultrasound contrast 
o f the tumor. The cores o f the nanoemulsion droplets or nanobubbles were formed by 
organic perfluoro- compounds; in this work, perfluoropentane (PFP) was used; the 
PFP was encased in the walls formed by the biodegradable amphiphilic block 
copolymer, poly(ethylene oxide)-co-poly(L-lactide) (PEG-PLLA) or poly(ethylene 
oxide-co-polycaprolactone (PEG-PCL).
Due to the impedance difference from the surrounding medium, not only 
perfluorocarbon bubbles but also droplets have echogenic properties; however bubbles 
manifest higher echogenicity than droplets, which allows using ultrasound imaging to 
monitor acoustic droplet vaporization (i.e. the ADV effect that was discovered and 
investigated in a series o f works by Kripfgans, Fowlkes et al. for a different type of 
perfluorocarbon emulsions [3], [4]). Besides producing high ultrasound contrast, 
bubbles serve as potent enhancers o f ultrasound-mediated drug delivery. Therefore 
nanodroplet vaporization in situ to generate bubbles is highly desirable for both 
ultrasonography and drug delivery. The PFP has a boiling temperature o f 29 °C thus 
producing nanoemulsions at room temperature. The ADV effects in PFP 
nanoemulsions stabilized by PEG-PLLA and PEG-PCL are described below. Another 
issue addressed in the paper is related to the ADV effect and bubble cavitation in 
highly viscous gel systems used as tissue models. This information is relevant to 
acoustic effects produced in tumor interstitium after bubble extravasation. The 
information on the acoustic properties o f these novel formulations obtained in this 
study was used for optimizing in vivo tumor imaging and therapy.
MATERIALS AND METHODS
Block copolymers. Block copolymers used in this study were bought from Polymer 
Source (Quebec, Canada). The PEG-PLLA copolymer had a total molecular weight o f 
9,700. The PEG-PCL copolymer had a total molecular weight o f 4,600 D.
Micellar solutions and drug loading. Micellar solutions o f the block copolymers 
were prepared by a solvent exchange technique as described in details previously [1]; 
DOX loading into the micelles was performed at the micelle preparation stage. 
Genexol-PM was bought from Samyang Corp. (Daejeon, South Korea) and dissolved 
in PEG-PLLA micellar solution.
Preparation o f  nanoemulsions. An aliquot o f PFP was pipetted into a 
corresponding micellar solution and sonicated by 20-kHz ultrasound in ice-cold water.
Nanoparticle size distribution. Size distribution o f nanoparticles was measured by 
dynamic light scattering at an angle o f 165° using Delsa Nano S instrument (Beckman 
Coulter, Osaka, Japan) equipped with a 658 nm laser and a temperature controller. 
Size distribution was analyzed using Non-Negative Least Squares (NNLS) method.
Sonication. Unfocused 1- or 3-MHz ultrasound was generated by an Omnisound 
3000 instrument (Accelerated Care Plus Inc, Sparks, NV) equipped with a 5 cm2 
transducer head.
Cavitation activity. Cavitation activity was assessed by measuring subharmonic, 
harmonic, and broadband noise amplitudes in a scattered beam. The microbubble 
formulation inserted in a Samco polyethylene transfer pipette (5 mm internal diameter, 
0.3 mm wall thickness, Fisher Scientific, Pittsburg, PA) was positioned at a distance
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o f 0.5 cm from the transducer that was housed in an open glass tank containing filtered 
distilled degassed water. To minimize possible standing wave formation, a 2.5 cm 
thick rubber liner was mounted opposite the transducer. Ultrasound pressure was 
measured using a needle hydrophone (HNR-1000, Onda, Sunnyvale, CA) with a 20 
dB preamplifier (AH-1100, Onda, Sunnyvale, CA). The hydrophone was placed 
perpendicular to the beam direction at a distance o f  3 cm from the sample.
Monitoring acoustic droplet vaporization by visual observation and ultrasound 
imaging. Formation o f  the microbubbles from the nanodroplets under the action o f 
ultrasound was monitored visually and by ultrasound imaging using a 7.5-MHz 
scanner (Scanner 250, Pie Medical, Maastricht, The Netherlands).
Cells and tumor models. Ovarian cancer A2780 cells were obtained from American 
Type Culture Collection (Manassas, VA). The cells were cultured and inoculated to 
nu/nu mice as described previously [1],
RESULTS AND DISCUSSION
Acoustic droplet vaporization
These experiments were performed for two types o f  the droplet stabilizing 
copolymers (PEG-PLLA and PEG-PCL) and two types o f  matrices (liquid (PBS) and 
gel (0.2% agarose or a bovine plasma clot) for 1-MHz or 3-MHz ultrasound. Some 
experiments were performed using low-frequency CW 90-kHz ultrasound generated in 
the ultrasound bath (SC-100, Sonicor Instrument Co., Copiague, NY) with intensity 
close to that o f  1-MHz ultrasound (peak-to-peak pressure o f  0.7 MPa). Ultrasound 
intensities that (a) induced the formation o f  the first visible bubbles; and (b) induced 
droplet-to-bubble transition in the whole volume o f  the sample were recorded.
For both emulsion types, the first visible bubbles were always formed on the distal 
wall o f  the container at low ultrasound intensities thus suggesting their nucleation in 
the surface crevices. In liquid systems, the onset o f  the droplet-to-bubble transition in 
the whole volume o f  the sample was accompanied by intensive bubble coalescence 
into the large bubbles that were raised to the sample surface thus mimicking sample 
boiling. In what follows, we call this phenomenon “global ADV”. The threshold o f  the 
global ADV was noticeably higher than that for the formation o f  first bubbles on the 
wall surface.
Effect o f  the type o f  droplet-stabilizing copolymer. For the droplets stabilized by a 
PEG-PCL copolymer, the ADV threshold was lower than that for the bubbles o f  the 
same composition stabilized by a PEG-PLLA copolymer; as an example, at room 
temperature and under 1-MHz ultrasound with a 20% duty cycle (1.2 ms pulse 
duration and 4.8 ms inter-pulse interval), the global ADV threshold for the 1% 
PFP/0.25% PEG-PCL system was 0.57 MPa compared to 0.85 MPa for the droplets o f 
the same composition stabilized by PEG-PLLA.
Effect o f  the duty cycle. The ADV threshold strongly depended on the ultrasound 
duty cycle and was significantly higher for pulsed ultrasound as compared to CW 
ultrasound. In PFP/PEG-PCL system, five-fold higher nominal ultrasound energy was 
required for initiating the global ADV effect by 1 -MHz ultrasound o f  20% duty cycle
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than by CW  ultrasound; moreover, in PFP/PEG-PLLA systems, pulsed ultrasound 
with 20% duty cycle did not induce global ADV effect while CW ultrasound did.
Effect o f  temperature. For both types o f  the emulsions, the ADV threshold was 
lower at 37 °C compared to room temperature. As an example, for 1% PFP/0.25% 
PEG-PCL system sonicated for 1 min by 1-MHz ultrasound with 20% duty cycle, 
ADV threshold dropped from 0.68 MPa at room temperature to 0.44 MPa at 37 °C.
Effect o f  ultrasound frequency. For both types o f  the emulsions, the ADV threshold 
was higher for 3-MFIz compared to 1 -MFIz ultrasound.
Effect o f gel matrices. While liquid systems can mimic bubble behavior in blood 
vessels, much more viscous environment surrounds the bubbles extravasated into the 
extracellular matrix in tumor tissue. Introduction o f  the nanodroplets into a gel matrix 
substantially hampered global formation o f  large bubbles. Visual observations and 
ultrasound imaging indicated the formation o f  isolated large bubbles (FIGURE 1(a), 
sonication by CW 1 -MFIz ultrasound at 1.18 MPa peak-to-peak pressure for 1 minute); 
for comparison, in PBS suspensions, an intensive global “boiling” was observed 
almost immediately at a pressure as low as 0.3 MPa. However the absence o f  the 
global formation o f  large bubbles does not signify the absence o f  the droplet-to-bubble 
transition. As indicated by the generation o f  harmonics and broadband noise (see 
below), ultrasound did induce droplet-to-bubble transition in gel matrices; however, 
gel precluded intensive bubble coalescence in the sample volume. FIGURE 1(a) 
suggests that the isolated bubbles formed under ultrasound initiated droplet-to-bubble 
transition in their immediate vicinity and grew by coalescence with these bubbles. 
This effect was much stronger at lower ultrasound frequencies; an example for gel 
sonication by 90-kHz ultrasound at 0.7 MPa is shown in FIGURE 1(b). For the 
optimal intratumoral drug delivery and imaging, it appears reasonable to modulate 
megahertz frequency range (which is required for ultrasound focusing) by a hundred 
kilohertz frequency range in therapeutic ultrasound.
Bubble Cavitation
For the effective drug delivery, the formation and cavitation o f  the 
nano/microbubbles from the nanoemulsions are extremely beneficial because the 
oscillation and cavitation o f  the bubbles trigger the release o f  the encapsulated drug 
and also perturb cell membranes thus enhancing the intracellular drug uptake. In the 
present study, the cavitation effects have been explored for unfocused ultrasound at a 
frequency o f  1 MHz. The appearance and amplitudes o f  harmonic frequencies and 
broad band noise were monitored in Fast Fourier Transform emission spectra. The 
representative data on the relative subharmonic peak amplitudes are shown in 
FIGURE 2(a) for the PFP/PEG-PCL emulsion in PBS and in FIGURE 2(b) for the 
droplets inserted in the agarose gel. The threshold o f  the stable bubble cavitation 
(about 0.5 MPa) is clearly seen in FIGURE 2(a) (but not in FIGURE 2(b) because the 
gel comprised some preexisting bubbles). To characterize inertial cavitation, we 
measured mean relative amplitude o f  a broadband noise in the frequency intervals that 
avoided fundamental, harmonic, and superharmonic frequencies. The data obtained 
clearly indicated that inertial cavitation o f  the bubbles proceeded in both liquid and gel 
systems at the ultrasound pressure o f  1.18 MPa that was chosen for in vivo
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experiments. The promising results o f in vivo studies are shown in FIGURE 3. 
Ovarian carcinoma tumors were grown in the left and right flank o f a mouse; PTX- 
loaded PEG-PLLA nanoemulsions were injected systemically; only one (the right) 
tumor was sonicated. The unsonicated tumor grew with the same rate as control 
indicating a strong retention o f the drug in the bubbles while the sonicated tumor was 
resolved after four treatments.
Very promising chemotherapy results were also obtained with DOX-loaded PEG- 
PCL nanoemulsion
(a) (b)
Figure 1. PFP/PEG-PCL microbubbles formed 
from the nanodroplets inserted in the bovine 
plasma clots under ultrasound of 1 MHz (a) or 90 
kHz (b).
(a) (b)
Figure 3. Treatment of the ovarian carcinoma 
by PEG-PLLA nanobubble-encapsulated 
paclitaxel; (a) before treatment; (b) three 
weeks after treatment.
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Stable cavitation as characterized by relative subharmonic amplitudes of the bubbles 
the ADV from the droplets inserted in PBS (a) or agarose gel (b)_______________________
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